Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 9/20 | 0.72 |
| ▸ | PPARA | Q07869 | 8/20 | 0.72 |
| ▸ | PPARD | Q03181 | 4/20 | 0.48 |
| ▸ | CACNA1B | Q00975 | 7/20 | 0.43 |
| ▸ | CACNA1H | O95180 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6004633 | 1.00 | PPARG (0.72) | PPARGPPARAPPARDCACNA1BCACNA1H | |
| SCHEMBL7514537 | 0.91 | PPARG (0.74) | PPARGPPARAPPARDCACNA1BCACNA1H | |
| SCHEMBL5342143 | 0.87 | PPARG (0.70) | PPARGPPARAPPARDCACNA1BCACNA1H | |
| SCHEMBL7928584 | 0.85 | PPARG (0.81) | PPARGPPARAPPARD | |
| SCHEMBL6002510 | 0.85 | PPARG (0.77) | PPARGPPARA | |
| Ragaglitazar SCHEMBL676872 | 0.84 | PPARA (1.00) | PPARGPPARAPPARD | |
| Ragaglitazar SCHEMBL29369224 | 0.84 | PPARA (1.00) | PPARGPPARAPPARD | |
| Ragaglitazar SCHEMBL682732 | 0.84 | PPARA (1.00) | PPARGPPARAPPARD | |
| Ragaglitazar SCHEMBL4822459 | 0.84 | PPARA (1.00) | PPARGPPARAPPARD | |
| Homatropine SCHEMBL5342141 | 0.82 | LMNA (0.55) | PPARGPPARAPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7223881-B2 | Process for the preparation of new antidiabetic agents | DR. REDDY'S LABORATORIES LIMITED (IN) | 2007-05-29 | — | — | US | disclosed |
| US-20030125553-A1 | Process for the preparation of new antidiabetic agents | DR. REDDY'S LABORATORIES LIMITED | 2003-07-03 | — | — | US | disclosed |
| WO-2003027084-A1 | IMPROVED PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE PHENOXAZINE DERIVATIVES AS ANTIDIABETIC AGENTS | DR. REDDY'S LABORATORIES LTD. (IN) | 2003-04-03 | — | — | WO | disclosed |
| US-6531596-B1 | S(-)-2-methoxy-3-(4-(2-(phenoxazin-10-yl)methoxy) phenyl)propionic acid; benzylating p-hydroxybenzaldehyde or tyrosine; reaction with phenoxazinyl mesylate | DR. REDDY'S LABORATORIES LTD. (IN) | 2003-03-11 | — | — | US | disclosed |
| WO-2003008397-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF ANTIDIABETIC PHENOXAZINE COMPOUNDS | DR. REDDY'S LABORATORIES LTD. (IN) | 2003-01-30 | — | — | WO | disclosed |
| EP-1124808-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF NEW ANTIDIABETIC AGENTS | DR. REDDY'S RESEARCH FOUNDATION (IN) | 2001-08-22 | — | — | EP | disclosed |
| WO-2000026200-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF NEW ANTIDIABETIC AGENTS | DR. REDDY'S RESEARCH FOUNDATION (IN) | 2000-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030125553-A1 | Process for the preparation of new antidiabetic agents | GLP1R, GPR119, SLC5A1 | PPARG 103/4885PPARA 108/4885PPARD 69/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.